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Abstract: Seven cadinane sesquiterpenoids, named boreovibrins A–G (1–7), three dihydrobenzofurans (8–10), and two lactones 
(11 and 12), together with one known compound (13), were isolated from cultures of the basidiomycete Boreostereum vibrans. The 
new structures were elucidated by means of spectroscopic methods. Compounds 5, 6, and 11 showed weak inhibitory activities 
against isozymes of 11β-hydroxysteroid dehydrogenases (11β-HSD). 
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Introduction 
Boreostereum vibrans is entitled as one of talent strains due 
to the discovery of a series of vibralactone derivatives.1–4 Of 
them, vibralactone showed significant inhibitory activity 
against pancreatic lipase with an IC50 value of 0.4 μg/mL,1 and 
its total synthesis has also been achieved.5 Vibralactone was 
also used as a tool to study the activity and structure of the 
CIpP1P2 complex from Listeria monocytogenes.6 Currently, 
our chemical study on the little modified cultivation conditions 
of the same source has led to the isolation of several different 
types of compounds, including seven new cadinane  
sesquiterpenoids, boreovibrins A–G (1–7), three new dihydro-
benzofurans (8–10), and two new lactones (11 and 12). Their 
structures were established by extensive spectroscopic data 
analysis. Meanwhile, a known compound was identified as 5-
(1′′,2′′-dihydroxypropyl)-2-isopropenyl-2,3-dihydrobenzofuran 
(13) by comparison with data in the literature.7 Compounds 2, 
3, 6, 8, 10, and 13 were evaluated for their cytotoxicities 
against five human cancer cell lines. The inhibitory effects of 
all the compounds on isozymes of 11β–hydroxysteroid  
dehydrogenases which catalyze the interconversion of active 
cortisol and inactive cortisone were also investigated. 
 
Results and Discussion 
Compound 1, a colorless oil, showed a molecular ion peak 
in the HREIMS at m/z 252.1729 [M]+, analyzing for C15H24O3 
with four degrees of unsaturation. The IR spectrum showed 
absorption bands attributable to hydroxy (3431 cm–1) and 
carboxyl (1707 cm–1) groups. The 13C NMR spectrum 
displayed 15 carbon signals for a carboxyl carbon, a 
trisubstituted double bond, an oxygenated sp3 quaternary 
carbon, four methylenes, four methines, and three methyls 
(Table 1). Beyond two degrees of unsaturation occupied by 
one double bond and a carboxyl carbon, compound 1 was 
required to possess a bicyclic system. In the 1H-1H COSY 
spectrum, a long chain was established as shown in Figure 1. 
In addition, preliminary analyses of HMBC correlations 
suggested that compound 1 was a cadinane sesquiterpenoid 
closely related to δ-cadinol.8 Further analyses of 2D NMR data 
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indicated the difference was that the methyl of C-12 in δ-
cadinol was oxygenated to a carboxyl group at δC 179.4 (s, C-
12) in 1 on the basis of HMBC correlation of δH 1.15 (3H, d, J 
= 7.1 Hz, H-13) and 2.81 (1H, m, H-11) to C-12, as well as the 
requirement of MS data. The relative configuration of 1 was 
elucidated by the ROESY experiment. In which, the 
correlation of H-1/H-6/H-15 indicated that they were in the 
same side, while the correlation of H-11/H-6 allowed H-7 to 
be in the opposite side (Figure 1). The absolute configuration 
of C-11 was determined by comparison with 13C NMR data of 
Me-13 with analogues reported in the literature,9 in which the 
13C NMR shift of Me-13 from δC 8.0 to 10.0 suggested the S 
form of C-11, while from δC 13.0 to 16.0 for R.9 In compound 
1, the 13C NMR shift of C-13 at δC 14.9 indicated the R form 
of C-11. Therefore, compound 1 was established to be 
boreovibrin A, as shown. 
Compound 2 possessed the same molecular formula as that 
of 1, while the IR and NMR data (Tables 1 and 2) were also 
closely related to those of 1. Analyses of 2D NMR data still 
suggested that compound 2 had the same planar structure to 
that of 1. However, the 13C NMR data for C-13 between the 
two compounds were quite different as shown in Table 1, 
which indicated that the absolute configuration of C-11 in 2 
should be S.9 The ROESY correlations of H-1/H-6/H-15 and 
H-11/H-6 also elucidated the relative configuration of these 
chiral carbons to be the same with those of 1. Thus, compound 
2 was approved as boreovibrin B, as shown. 
Compound 3 was isolated as a colorless oil. Its molecular 
formula C17H26O5 was determined by the HRESIMS at m/z 
333.1672 [M + Na]+. The NMR data (Tables 1 and 2) were 
very similar to those of 2 except for the methyl of C-14 in 2 
was oxygenated to a hydroxymethylene (δC 68.2, t) in 3 as 
indicated by the HMBC correlation of δH 4.46 (2H, br. s, H-14) 
with C-4. In addition, the acetoxylation of the 
hydroxymethylene was established by the HMBC correlation 
from δH 4.46 (br. s, H-14) to δC 171.3 (s, OAc). Analysis of the 
ROESY spectrum and the comparison of 13C NMR data of C-
13 established the stereoconfiguration of 3 the same as that of 
2. Hence, compound 3 was identified as boreovibrin C. 
Compound 4 was obtained as a colorless oil. Its molecular 
formula was established as C17H24O4 by the negative 
HRESIMS at m/z 291.1589 [M – H]– (calcd for 291.1596). 
The IR spectrum showed absorption bands at 3424 cm–1 and 
1739 cm–1, corresponding to hydroxy and carbonyl groups, 
respectively. The 1H and 13C NMR data (Tables 1 and 2) were 
very similar to those of 3 including the presence of an 
oxymethylene linked by an acetoxyl group and a carboxyl at 
δC 176.5 (s, C-12). However, a terminal double bond was 
detected and assigned between C-10 and C-15 by the HMBC 
correlation from δH 4.61 and 4.68 (each 1H, br. s, H-15) to δC 
153.5 (s, C-10), 44.1 (d, C-1), and 31.9 (t, C-9). The 
downfield 13C NMR shift of C-13 (δC 15.4, q) indicated R 
configuration of C-11. Thus, compound 4 was established as 
boreovibrin D, as shown. 
A negative HRESIMS revealed compound 5 to possess the 
molecular formula C17H24O5 by the [M – H]– peak at m/z 
307.1554, indicating six degrees of unsaturation. The IR 
spectrum suggested the presence of carbonyl (1740 cm–1) and 
hydroxy (3443 cm–1) groups. Compound 5 had NMR data 
(Tables 1 and 2) similar to those of 3. However, the existence 
of an oxygenated sp3 quaternary carbon at δC 81.0 (s) in 5 
indicated the key difference between them. The HMBC 
correlations from H-1, H-5, and H-7 to δC 81.0 (s) assigned the 
oxygenated sp3 quaternary carbon to be C-6. By comparison of 
13C NMR data with reported in the literature,10 as well as the 
analysis of MS data, compound 5 was suggested to possess a 
γ-lactone ring as constructed by C-6, C-7, C-11, and C-12. The 
ROESY correlation observed between H-7 and Me-13 (not 
observed between H-7 and H-11) not only supported the γ-
lactone ring as deduced above but also elucidated the relative 
configuration of Me-13 to be the same side with H-7. Detailed 
analysis of other 2D NMR data suggested that the other parts 
were the same to those of 3. Therefore, compound 5 was 
established as boreovibrin E. 
Compound 6, a colorless oil, possessed a molecular formula 
C19H30O5 as established by the HRESIMS at m/z 361.1995 [M 
+ Na]+. The IR spectrum showed the presence of carbonyl 
(1739 cm–1) and hydroxy (3455 cm–1) groups. The 1H and 13C 
NMR data (Tables 1 and 2) of 6 showed similar patterns to 
those of 3. However, the lost of the carboxyl carbon in 3 and 
the presence of an oxymethylene signal (δC 69.1, t) in 6 
indicated the modification of C-12, which was supported by 
the HMBC correlation of H-11 to C-12, as well as the 1H-1H 
COSY cross peak between δH 2.10 (1H, m, H-11) and 3.93 
(2H, d, J = 7.2 Hz, H-12). In addition, an additional acetoxy 
group was connected to C-12 as indicated by the HMBC 
Table 1. 13C NMR data for compounds 1–7 
position 1 2 3 4 5 6 7
1 45.5 (d) 46.7 (d) 45.2 (d) 44.1 (d) 44.1 (d) 45.7 (d) 72.4 (s) 
2 18.4 (t) 19.2 (t) 17.8 (t) 25.3 (t) 18.1 (t) 18.3 (t) 21.6 (t)
3 31.2 (t) 31.9 (t) 26.9 (t) 27.1 (t) 24.2 (t) 27.4 (t) 22..7 (t) 
4 135.8 (s) 136.1 (s) 134.9 (s) 134.6 (s) 145.9 (s) 134.5 (s) 132.9 (s) 
5 123.9 (d) 124.6 (d) 127.2 (d) 128.9 (d) 124.5 (d) 128.7 (d) 127.2 (d) 
6 37.0 (d) 36.8 (d) 36.1 (d) 40.5 (d) 81.0 (s) 36.3 (d) 46.1 (d) 
7 43.3 (d) 41.8 (d) 40.5 (d) 44.1 (d) 49.6 (d) 40.2 (d) 55.3 (d) 
8 24.8 (t) 24.3 (t) 23.8 (t) 29.6 (t) 18.7 (t) 22.7 (t) 71.1 (d) 
9 35.3 (t) 35.7 (t) 34.8 (t) 31.9 (t) 34.9 (t) 35.2 (t) 40.9 (t) 
10 72.6 (s) 71.4 (s) 71.9 (s) 153.5 (s) 72.7 (s) 72.4 (s) 39.4 (d) 
11 39.3 (d) 39.5 (d) 39.2 (d) 40.0 (d) 36.9 (d) 31.9 (d) 26.7 (d) 
12 179.4 (s) 177.5 (s) 181.4 (s) 176.5 (s) 178.6 (s) 69.1 (t) 19.8 (q)
13 14.9 (q) 9.7 (q) 9.7 (q) 15.4 (q) 13.8 (q) 11.0 (q) 20.9 (q) 
14 23.8 (q) 23.9 (q) 68.2 (t) 68.8 (t) 67.2 (t) 68.9 (t) 68.4 (t) 
15 28.2 (q) 28.5 (q) 27.9 (q) 107.9 (t) 28.3 (q) 28.3 (q) 15.0 (q) 
12-OCOCH3      21.4 (q)  
12-OCOCH3      171.4 (s)  
14-OCOCH3   20.9 (q) 20.9 (q) 21.2 (q) 21.4 (q) 21.2 (q) 
14-OCOCH3   171.3 (s) 170.9 (s) 171.0 (s) 171.7 (s) 171.2 (s) 
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correlation from H-12 to δC 171.4 (s, OAc). The ROESY 
correlations of H-1/H-6/H-15 and H-6/H-11 indicated the 
same relative configuration as that of 3. Therefore, compound 
6 was elucidated as boreovibrin F. 
Compound 7 was obtained as a colorless oil. The molecular 
formula was found to be C17H28O4 by HRESIMS at m/z 
319.1885 [M + Na]+. The IR spectrum showed the presence of 
hydroxy (3425 cm–1) and carbonyl (1736 cm–1) groups. In the 
13C NMR spectrum (Table 1), one acetoxy group was readily 
identified. Besides, the other fifteen carbons indicated that 
compound 7 was still a cadinane sesquiterpenoid and 
displayed some similar patterns to those of 3. The 1H-1H 
COSY spectrum displayed two fragments as shown in figure 1, 
from which a hydroxy substituted carbon assigned as C-8 (δC 
71.1, d) and an isopropyl connected to C-7 were established. 
In addition, an oxygenated sp3 quaternary carbon at δC 72.4 (s) 
was assigned as C-1 on the basis of HMBC correlations from 
H-2, H-6, and H-10 to C-1 (Figure 1). Further analysis of 
HMBC spectrum indicated that the other parts of 7 were the 
same as those of 3. The ROESY correlations of H-6/H-15/H-8 
and H-6/H-11 indicated H-6 and H-8 in the same side, while 
H-7 and H-10 in the opposite side. Furthermore, the ROESY 
correlations of H-10/H-2b and H-2a/H-6 allowed the OH at C-
1 to be the same side with C-15. Thus, compound 7 was 
established as boreovibrin G, as shown. 
Compound 8 was obtained as a colorless oil with the 
molecular formula of C14H16O4 based on the HREIMS at m/z 
248.1037 [M]+ (calcd 248.1049 for C14H16O4), with seven 
degrees of unsaturation. The IR absorption bands at 3431 and 
1737 cm−1 indicated the presence of OH and CO groups. In the 
1H NMR spectrum (Table 3), the signals of δH 7.19 (1H, s, H-
4), 7.14 (1H, d, J = 8.1 Hz, H-6), and 6.79 (1H, d, J = 8.1 Hz, 
H-7) are typical for a 1,2,4-trisubstituted benzene ring. An 
acetoxy group was identified to be connected to an 
oxymethylene (δC 66.4, t, C-1′′) at C-5 (δC 128.4, s) on the 
basis of HMBC correlations. In addition to these carbons, the 
13C NMR spectrum displayed other five carbon resonances 
ascribable for a terminal double bond, two methylenes (one 
oxygenated), and one oxygenated methine (Table 3), which 
were likely to assemble an isopentyl group. All these data 
indicated that the structure of 8 was closely related to that of 
5-hydroxymethyl-2-isopropenyl-2,3-dihydrobenzofuran.11 The 
key difference was the additional acetyl (δC 170.5, s) and 
hydroxymethyl (δC 63.6, t, C-2′) groups in 8. This assignment 
was confirmed by the HMBC correlations of H-3′/C-2′, and of 
to H-1′′/δC 170.5 (s, OAc). Detailed analysis of the 2D NMR 
data indicated the other parts of 8 to be the same as those of 5-
hydroxymethyl-2-isopropenyl-2,3-dihydrobenzofuran,11 while 
the similarity of specific rotations between 8 ([α]16D   = + 18.1) 
and 5-hydroxymethyl-2-isopropenyl-2,3-dihydrobenzofuran 
([α]21D   = + 20.8) indicated the S configuration of C-2. Therefore,
compound 8 was elucidated as 5-(1′′-acetyloxymethylene)-2-
hydroxyisopropenyl-2,3-dihydrobenzofuran. 
Table 2. 1H NMR data for compounds 1–7 
position 1 2 3 4 5 6 7 
1 1.61 (m) 1.57 (m) 1.69 (m) 2.40 (m) 2.12 (m) 1.65 (m)  
2a 1.89 (m) 2.04 (m) 2.01 (m) 1.97 (m) 2.18 (m) 2.00 (m) 1.74 (m) 
2b 1.51 (m) 1.51 (m) 1.60 (m) 1.45 (m) 2.10 (m) 1.55 (overlapped) 1.65 (m) 
3a 1.98 (m) 1.96 (overlapped) 2.15 (m) 2.09 (m) 2.53 (m) 2.13 (overlapped) 2.15 (m) 
3b   2.03 (m)  2.01 (m) 2.03 (m)  
5 5.62 (d, 4.1) 5.52 (d, 4.6) 5.76 (d, 4.9) 6.07 (d, 5.1) 5.61 (s) 5.81 (d, 5.2) 5.80 (d, 5.6) 
6 2.16 (m) 2.03 (m) 2.11 (m) 2.19 (m)  2.15 (overlapped) 1.85 (m) 
7 1.58 (m) 1.95 (overlapped) 2.00 (overlapped) 1.76 (m) 2.13 (m) 1.56 (overlapped) 1.22 (m) 
8a 1.66 (m) 1.29 (m) 1.43 (m) 1.84 (m) 1.92 (m) 1.42 (m) 3.61 (m) 
8b 1.31 (m)  1.32 (m) 1.18 (m) 1.71 (m) 1.22 (m)  
9a 1.58 (m) 1.60 (m) 1.62 (m) 2.19 (m) 1.63 (m) 1.57 (overlapped) 1.80 (m) 
9b 1.51 (m) 1.43 (m) 1.52 (m)  1.56 (m) 1.52 (m) 1.25 (m) 
10       1.73 (m) 
11 2.81 (m) 2.78 (m) 2.77 (m) 2.78 (m) 2.68 (m) 2.10 (m) 2.16 (m) 
12      3.93 (d, 7.2) 1.06 (d, 7.1) 
13 1.15 (d, 7.1) 1.03 (d, 7.1) 1.10 (d, 7.1) 1.12 (d, 7.1) 1.28 (d, 7.1) 0.90 (d, 7.0) 1.00 (d, 7.0) 
14a 1.63 (s) 1.65 (s) 4.46 (br. s) 4.47 (d, 12.3) 4.55 (d, 12.0) 4.46 (s) 4.50 (d, 12.4) 
14b    4.43 (d, 12.4) 4.54 (d, 12.0)  4.49 (d, 12.5) 
15a 1.27 (s) 1.26 (s) 1.31 (s) 4.68 (br. s) 1.33 (s) 1.31 (s) 0.99 (d, 6.8) 
15b    4.61 (br. s)    
12-OAc      2.06 (s)  
14-OAc   2.07 (s) 2.01 (s) 2.12 (s) 2.08 (s) 2.06 (s) 
 
Figure 1.  Selected 2D NMR correlations of 1 and 7 
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Compound 9 was a colorless oil and gave a molecular 
formula of C14H18O5 by HRESIMS at m/z 265.1072 [M – H]– 
(calcd for 265.1075). The NMR data were similar to those of 8 
with the major differences being that the terminal double bond 
was absent instead of a methyl (δC 19.7, q, C-3′) and an 
oxygenated sp3 quaternary carbon (δC 73.8, s, C-1′) as 
supported by the HMBC correlations. Compound 9 was 
determined to be 5-(1′′-acetyloxymethylene)-2-(1,2-
dihydroxyisopropyl)-2,3-dihydrobenzofuran. 
Compound 10 was purified as a colorless oil with the 
molecular formula of C16H20O6 based on the HREIMS at m/z 
308.1262 [M]+ (calcd for 308.1260). The NMR data (Table 3) 
of 10 were very similar to those of 9 except for signals of an 
additional acetoxyl group. This acetoxyl group could be 
readily identified to be connected to C-2′ due to the HMBC 
correlation from δH 4.13 and 4.33 (each 1H, d, J = 11.3 Hz, H-
2′) to δC 171.3 (s, OAc). Therefore, compound 10 was 
established as 5-(1′′-acetyloxymethylene)-2-(1-O-acetyl-1,2-
hydroxyisopropyl)-2,3-dihydrobenzofuran. 
Compound 11 was isolated as a colorless oil with the 
molecular formula of C9H14O3 based on the HRESIMS at m/z 
193.0837 [M + Na]+, indicating three degrees of unsaturation. 
The 13C NMR spectrum showed nine carbon signals ascribable 
for a carbonyl group, a double bond, two methylenes, two 
methines, and two methyls (Table 4). On the basis of the 
above evidence, compound 11 was suggested to be a single 
ring molecule. In the 1H-1H COSY spectrum, a fragment of 
CH3-CH-CH2-CH- was established readily, while the HMBC 
correlation of δH 5.40 (1H, m, H-5) with δC 180.1 (s, C-2) 
established a five-membered lactone ring. In addition, the 
HMBC correlations of a methyl signal at δH 1.82 (3H, s, H-9) 
and an oxygenated methylene signals at δH 4.20 (1H, d, J = 
12.0 Hz, H-10a) and 4.17 (1H, d, J = 12.0 Hz, H-10b) with δC 
125.7 (d, C-7) suggested the existence of an oxygenated 
isobutylene group connected to C-5. The ROESY correlations 
of H-5/H-4a and H-4b/H-3 suggested that H-3 and H-5 were in 
the opposite side, while the ROESY correlation between H-7 
and H-9 indicated the Z-form of the double bond of C(7)=C(8). 
Therefore, compound 11 was established as 6-methyl-5-(10-
oxymethylene-isobutylene)-lactone. 
Compound 12, a colorless oil, possessed a molecular 
formula C11H16O4, as established on the basis of ESIMS (m/z 
235 [M + Na]+), in combination with 1D NMR and HSQC 
spectra analysis. According to the NMR data (Table 4), 
compound 12 was readily identified as the acetoxylated 
product of 11. The acetoxyl group was identified to be 
connected to C-10 on the basis of HMBC correlation of δH 
4.78 and 4.50 (each 1H, d, J = 12.5 Hz, H-10) with δC 171.0 (s, 
OAc). Detailed analysis of 2D NMR data (HSQC, HMBC, 
ROESY) indicated the other parts were the same to those of 11. 
Therefore, compound 12 was determined to 6-methyl-5-(10-O-
acetyl-isobutylene)-lactone. 
Compounds 2, 3, 6, 8, 10, and 13 were evaluated for their 
cytotoxicity against five human cancer cell lines using the 
MTT method as reported previously.12 Unfortunately, no  
compound showed significant activity (IC50 values > 8 μM). In 
addition, the inhibitory effects of all the compounds on human 
and mouse 11β-HSD1 were also investigated. As a result,  
boreovibrin F (6) showed moderate inhibitory activities 
against 11β-HSD1 (human IC50 = 46.7 μM; mouse IC50 = 66.4 μM), while boreovibrin E (5) and 6-methyl-5-(10-
oxymethylenes-isobutylene)-lactone (11) showed weak  
activities (46.8% and 41.6% inhibitions at 1.0 μM, respectively)
against human 11β-HSD1. 
Table 3. 1H and 13C NMR data for compounds 8–10 ( in ppm and J in Hz) 
 
position 
8 9 10 
δH δC δH δC δH δC 
2 5.35 (dd, 9.0, 8.9) 83.9 (d) 4.86 (dd, 9.5, 8.6) 86.2 (d) 4.79 (dd, 9.3, 9.2) 86.1 (d) 
3 3.43 (dd, 15.6, 9.0) 
3.18 (dd, 15.6, 8.9) 
35.1 (t) 3.43 (dd, 15.6, 9.5) 
3.18 (dd, 15.6, 8.6) 
29.8 (t) 3.33 (dd, 15.5, 9.2) 
3.17 (dd, 15.8, 9.3) 
29.9 (t) 
3a  126.9 (s)  128.9 (s)  127.1 (s) 
4 7.19 (s) 125.6 (d) 7.20 (br. s) 126.5 (d) 7.20 (s) 125.6 (d)
5  128.4 (s)  129. 1 (s)  128.6 (s) 
6 7.14 (d, 8.1) 129.1 (d) 7.10 (d, 8.1) 129.5 (d) 7.13 (d, 8.0) 129.0 (d) 
7 6.79 (d, 8.1) 109.2 (d) 6.66 (d, 8.1) 109.3 (d) 6.77 (d, 8.0) 109.2 (d) 
7a  159.5 (s)  161.1 (s)  159.9 (s) 
1′  147.4 (s)  73.8 (s)  72.7 (s) 
2′ 4.28 (d, 13.5) 
4.25 (d, 13.5) 
63.6 (t) 3.66 (m) 
3.56 (m) 
67.8 (t) 4.33 (d, 11.3) 
4.13 (d, 11.3) 
68.5 (t) 
3′ 5.26 (br. s) 112.5 (t) 1.15 (s) 19.7 (q) 1.24 (s) 19.9 (q) 
1′′ 5.01 (s) 66.4 (t) 4.96 (s) 66.8 (t) 5.01 (s) 66.3 (t) 
2′-OCOCH3     2.13 (s) 20.8 (q) 
2′-OCOCH3   171.3 (s)
1′′-OCOCH3 2.08 (s) 21.0 (q) 1.99 (s) 21.0 (q) 2.08 (s) 21.0 (q) 
1′′-OCOCH3  170.5 (s)  170.9 (s)  171.5 (s) 
Table 4. 1H and 13C NMR data of compounds 11 and 12 (CDCl3, 




δH δC δH δC 
2  180.1 (s)  180.0 (s) 
3 2.77 (m) 34.5 (d) 2.72 (m) 34.3 (d) 
4a 2.21 (m) 37.3 (t) 2.15 (m) 37.1 (t) 
4b 2.13 (m)  2.10 (m)  
5 5.40 (m) 74.1 (d) 5.34 (m) 74.1 (d) 
6 1.32 (d, 6.0) 15.9 (q) 1.31 (d, 6.0) 15.9 (q) 
7 5.41 (br. s) 125.7 (d) 5.48 (d, 8.7) 127.9 (d) 
8  142.0 (s)  136.7 (s) 
9 1.88 (s) 21.6 (s) 1.80 (s) 21.7 (s) 
10a 4.26 (d, 12.0) 62.1 (t) 4.78 (d, 12.5) 62.7 (t) 
10b 4.22 (d, 12.0)  4.50 (d, 12.5)  
10-OCOCH3   2.09 (s) 21.1 (q) 
10-OCOCH3    171.0 (s) 
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Experimental Section 
General Experimental Procedures. Optical rotations (OR) 
were recorded on a Jasco P-1020 digital polarimeter. UV data 
were obtained on a Shimadzu UV-2401A spectrophotometer. 
Infrared spectroscopy (IR) spectra were obtained on a Bruker 
Tensor 27 FT-IR spectrometer with KBr pellets. Nuclear 
Magnetic Resonance (NMR) spectra were obtained on Bruker 
AV-400 and DRX-500 instruments, and a Bruker Avance III 
600 MHz spectrometer with tetramethylsilane (TMS) as an 
internal standard at room temperature. Mass spectra were  
recorded on a VG Autospec-3000 mass spectrometer and an 
API QSTAR Pulsar I spectrometer. Silica gel (200–300 mesh, 
Qingdao Marine Chemical Ltd., China) and Sephadex LH-20 
(Amersham Biosciences, Sweden) were used for open column 
chromatography (CC). Fractions were monitored by TLC. 
Spots were visualized by heating silica gel plates immersed in 
Vanillin-H2SO4 in ethanol. 
 
Fungal Material and Cultivation Conditions. B. vibrans 
was provided and fermented by Zheng-Hui Li, Kunming  
Institute of Botany. A voucher specimen was deposited in the 
Herbarium of Kunming Institute of Botany, Chinese Academy 
of Sciences. The culture medium consisted of glucose (5%), 
peptone from porcine meat (0.15%), yeast powder (0.5%), 
KH2PO4 (0.05%) and MgSO4 (0.05%). The fungus was 
grown in seeding tank (inoculation volume 10%, 250 rpm,  
24 oC, aeration 1.0 vvm, 6 days). Fermentation was carried 
out in a fermenter (60 L working volume) for 20 days. 
 
Extraction and Isolation. The culture broth (60 L) was  
filtered, and the filtrate was extracted three times with EtOAc 
while the mycelium was extracted three times with CH3Cl-
MeOH (1:1). The EtOAc layer together with the mycelium 
extraction was concentrated under reduced pressure to give a 
crude extract (62 g), and this residue was subjected to CC over 
silica gel (200–300 mesh) eluted with a gradient of  CH3Cl-
MeOH (1:0 → 0:1) to obtain five fractions (1–5). Fraction 3 
was first separated by silica gel CC eluted with petroleum 
ether/Acetone gradient (6:1 → 3:1, v/v), then prepared by 
reverse-phased RP-18 CC (MeOH/H2O, 5:5 → 9:1, v/v) and 
Sephadex LH-20 (CHCl3/MeOH, 1 : 1) to afford 13 (30.0 mg), 
2 (2.8 mg), 11 (2.2 mg), 1 (2.2 mg), 6 (2.2 mg), 5 (1.0 mg), 7 
(1.7 mg), 8 (2.0 mg), 10 (2.2 mg), 12 (0.7 mg), 4 (2.0 mg), and 
9 (4.6 mg). Fraction 4 was separated repeatedly by  
reverse-phased RP-18 CC (MeOH/H2O, 3:7, v/v), followed by 
Sephadex LH-20 (CHCl3/MeOH, 1 : 1) to give 3 (2.7 mg). 
 
Boreovibrin A (1): colorless oil; [α] 17D   + 14.6 (c 0.28, 
MeOH); IR (KBr) νmax 3431, 2925, 1707, 1628, 1461, 1237, 
1125 cm–1; 1H (600 MHz) and 13C (150 MHz) data (CDCl3) 
see Tables 1 and 2; HREIMS m/z 252.1729 [M]+ (calcd for 
C15H24O3, 252.1725). 
 
Boreovibrin B (2): colorless oil; [α] 17D   + 32.2 (c 0.28, 
MeOH); IR (KBr) νmax 3472, 2949, 2927, 1711, 1627, 1459, 
1207, 1130 cm–1; 1H (600 MHz) and 13C (150 MHz) data  
(acetone-d6) see Tables 1 and 2; positive ion HRESIMS m/z 
275.1618 [M + Na]+ (calcd for C15H24O3Na, 275.1623). 
 
Boreovibrin C (3): colorless oil; [α] 16D   + 23.5 (c 0.27, 
MeOH); IR (KBr) νmax 3432, 2935, 2938, 1736, 1618, 1460, 
1379, 1238, 1026 cm–1; 1H (400 MHz) and 13C (125 MHz) 
data (CDCl3) see Tables 1 and 2; positive ion HRESIMS m/z 
333.1672 [M + Na]+ (calcd for C17H26O5Na, 333.1677). 
 
Boreovibrin D (4): colorless oil; [α] 18D   + 11.2 (c 0.20, 
MeOH); IR (KBr) νmax 3424, 2929, 1739, 1705, 1646, 1453, 
1378, 1235, 1025 cm–1; 1H (600 MHz) and 13C (150 MHz) 
data (acetone-d6) see Tables 1 and 2; negative ion HRESIMS 
m/z 291.1589 [M – H]– (calcd for C17H23O4, 291.1596). 
 
Boreovibrin E (5): colorless oil; [α] 19D   – 50.2 (c 0.10, 
MeOH); IR (KBr) νmax 3443, 2932, 1740, 1639, 1449, 1376, 
1239, 1052 cm–1; 1H (600 MHz) and 13C (150 MHz) data 
(CDCl3) see Tables 1 and 2; negative ion HRESIMS m/z 
307.1554 [M – H]– (calcd for C17H23O5, 307.1545). 
 
Boreovibrin F (6): colorless oil; [α] 16D   + 38.1 (c 0.31, 
MeOH); IR (KBr) νmax 3455, 2964, 2938, 1739, 1619, 1460, 
1370, 1239, 1036 cm–1; 1H (400 MHz) and 13C (100 MHz) 
data (CDCl3) see Tables 1 and 2; positive ion HRESIMS m/z 
361.1995 [M + Na]+ (calcd for C19H30O5Na, 361.1990). 
 
Boreovibrin G (7): colorless oil; [α] 18D   + 24.98 (c 0.17, 
MeOH); IR (KBr) νmax 3425, 2955, 2933, 1736, 1641, 1452, 
1376, 1242, 1027 cm–1; 1H (600 MHz) and 13C (150 MHz) 
data (CDCl3) see Tables 1 and 2; positive ion HRESIMS m/z 
319.1885 [M + Na]+ (calcd for C17H28O4Na, 319.1885). 
 
5-(1′′-Acetyloxymethylene)-2-hydroxyisopropenyl-2,3-
dihydrobenzofuran (8): colorless oil; [α]16D   + 18.1 (c 0.20, 
MeOH); UV (MeOH) λmax (log ε) 202 (3.78), 232 (3.23), 284 
(2.76) nm; IR (KBr) νmax 3431, 2925, 1737, 1657, 1639, 1614, 
1548, 1492, 1249, 1025 cm–1; 1H (400 MHz) and 13C (125 
MHz) data (CDCl3) see Table 3; HREIMS m/z 248.1037 [M]+ 
(calcd for C14H16O4, 248.1049). 
 
5-(1′′-Acetyloxymethylene)-2-(1,2-dihydroxyisopropyl)-
2,3-dihydrobenzofuran (9): colorless oil; [α] 17D   + 21.97 (c 
0.46, MeOH); UV (MeOH) λmax (log ε) 202 (3.47), 232 (2.89), 
284 (2.45), 368 (1.27) nm; IR (KBr) νmax 3424, 2931, 1736, 
1615, 1494, 1239, 1027 cm–1; 1H (600 MHz) and 13C 
(150MHz) data (acetone-d6) see Table 3; negative ion 




isopropyl)-2,3-dihydrobenzofuran (10): colorless oil; [α]16D   + 
29.4 (c 0.22, MeOH); UV (MeOH) λmax (log ε) 202 (3.60), 232 
(3.05), 283 (2.57) nm; IR (KBr) νmax 3444, 2928, 1738, 1657, 
1638, 1616, 1550, 1494, 1239, 1028 cm–1; 1H (400 MHz) and 
13C (125 MHz) data (CDCl3) see Table 3; positive ion 
HREIMS m/z 308.1262 [M]+ (calcd for C16H20O6, 308.1260). 
 
6-Methyl-5-(10-oxymethylene-isobutylene)-lactone (11): 
colorless oil; [α]17D   + 22.5 (c 0.28, MeOH); IR (KBr) νmax 3426, 
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2934, 1767, 1453, 1380, 1189, 1040 cm–1; 1H (400 MHz) and 
13C (150 MHz) data (CDCl3) see Table 4; positive ion 




less oil; [α]17D   + 34.0 (c 0.07, MeOH); IR (KBr) νmax 3441, 
2934, 1772, 1740, 1453, 1378, 1234, 1192 cm–1; 1H (600 MHz) 
and 13C (150 MHz) data (CDCl3) see Table 4; positive ion 
ESIMS m/z 235 [M + Na]+. 
 
Cytotoxicity Assay. Five human cancer cell lines: breast 
cancer SK-BR-3, hepatocellular carcinoma SMMC-7721,  
human myeloid leukemia HL-60, pancreatic cancer PANC-1, 
and lung cancer A-549 cells, were used in the cytotoxic assay. 
Cells were cultured in RPMI-1640 or in DMEM medium  
(Hyclone, USA), supplemented with 10% fetal bovine serum 
(Hyclone, USA) in 5% CO2 at 37 C. The cytotoxicity assay 
was performed according to the MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide) method in 96-well 
microplates.12 Briefly, 100 µL of adherent cells were seeded 
into each well of 96-well cell culture plates and allowed to 
adhere for 12 h before addition of test compounds, while sus-
pended cells were seeded just before drug addition with initial 
density of 1 × 105 cells/mL. Each tumor cell line was exposed 
to the test compound at concentrations of 0.0625, 0.32, 1.6, 
and 8 μM in triplicates for 48 h, with cisplatin (sigma, USA) 
as positive control. After compound treatment, cell viability 
was detected and a cell growth curve was graphed. IC50 values 
were calculated by Reed and Muench’s method.13 
 
Inhibition on 11β-HSD1 Activity Assays. The inhibition 
activity of compounds on human or mouse 11β-HSD1  
enzymatic activities was determined in the scintillation  
proximity assay (SPA) using microsomes containing 11β-
HSD1 as described in previous studies.14 Briefly, the full 
fulllength cDNAs of human or murine 11β-HSD1 were isolated
from the cDNA libraries provided by the NIH Mammalian 
Gene Collection and cloned into a pcDNA3 expression vector. 
HEK-293 cells were transfected with the pcDNA3-derived 
expression plasmid and selected after cultivation in the pres-
ence of 700 μg/mL of G418. The microsomal fraction overex-
pressing 11β-HSD1 was prepared from the HEK-293 cells 
stably transfected with 11β-HSD1 and used as the enzyme 
source for Scintillation Proximity Assay (SPA). Microsomes 
containing human or mouse 11β-HSD1 were incubated with 
NADPH and [3H]cortisone, and then the product [3H]cortisol 
was specifically captured by a monoclonal antibody coupled to 
protein A-coated SPA beads. All experiments were done in 
duplicate with glycyrrhizininc acid as a positive control. IC50 
(± S.D., n = 2) values were calculated using Prism Version 4 
(GraphPad Software, San Diego, CA, U.S.A.). IC50 values of 
glycyrrhizininc acid (positive control) are 5.41, and 8.42 nM 
for mouse 11β-HSD1, and human11β-HSD1, respectively. 
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